Association of Inflammatory Markers with Disease Severity and Outcome in Covid-19 Patients

1 B1. Gao Z, Xu Y, Sun C, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021; 54: 12–16. Search in Google Scholar

2 Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med 2020; 383: 2255-2273. Search in Google Scholar

3 Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol 2020; 7: e671-e678. Search in Google Scholar

4 Yang A-P, Liu J, Tao W, Li H, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020; 84: 106504. Search in Google Scholar

5 Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 2020; 395: 1033-1034. Search in Google Scholar

6 Sakthivadivel V, Bohra GK, Maithilikarpagaselvi N, Khichar S, Meena M, Palanisamy N, Gaur A, Garg MK, et al. Association of Inflammatory Markers with COVID-19 Outcome among Hospitalized Patients: Experience from a Tertiary Healthcare Center in Western India. MAEDICA – a Journal of Clinical Medicine. 2021; 16(4): 620-627. Search in Google Scholar

7 Sun H, Guo P, Zhang L, Wang F et al. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020. Med Sci Monit Int Med J Exp Clin Res 2020; 26: e926941-1-e926941-6. Search in Google Scholar

8 Henry BM, et al., Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med, 2020; 38(9): 1722–1726. Search in Google Scholar

9 Huang ., et al., C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease- 2019: a meta-analysis. Ther Adv Respir Dis, 2020; 14: 1753466620937175. Search in Google Scholar

10 Du RH, et al., Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV-2:a prospective cohort study. Eur Respir J, 2020; 55(5). Search in Google Scholar

11 Tang N, et al., Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 2020; 18(4): 844–847. Search in Google Scholar

12 Zhu Y, et al., Chinese Society of Interventional Radiology Expert Consensus on the prevention and control of COVID-19 in interventional radiology procedures (first edition). Quant Imaging Med Surg, 2020; 10(5): 1045–1057. Search in Google Scholar

13 Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020; 71: 762-768. Search in Google Scholar

14 Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020; 146: 110. Search in Google Scholar

15 Guan WJ, et al., Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 2020; 382(18): 1708–1720. Search in Google Scholar

16 Chen N, et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020:507-513. Search in Google Scholar

17 Luo X, et al., Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019. Clin Infect Dis, 2020; 71(16): 2174–2179. Search in Google Scholar

18 Chen T, et al., Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ, 2020; 368: m1091. Search in Google Scholar

19 Gao Y, et al., Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol, 2020; 92(7): 791–796. Search in Google Scholar

20 Hachim IY, Hachim MY, Hannawi H, Naeem KB, Salah A, Hannawi S, et al. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient’s outcome: A single centered study. PLoS ONE 16(12): e0260537. Search in Google Scholar

21 Zhang JJ, et al., Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020; 75(7): 1730–1741. Search in Google Scholar

22 Wang D, et al., Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020; 323(11): 1061–1069. Search in Google Scholar

23 Lippi G and Plebani M, Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta, 2020; 505: 190–191. Search in Google Scholar

24 24. Martinez-Outschoorn UE, Ketones and lac-tate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle, 2011; 10(8): 1271–86. Search in Google Scholar

25 Bartziokas K and Kostikas K, Lactate dehydrogenase, COVID-19 and mortality. Med Clin (Engl Ed), 2021; 156(1): 37. Search in Google Scholar

26 Bhandari S, Rankawat G, Singh A, et al. Evaluation of interleukin-6 and its association with the severity of disease in COVID-19 patients. Indian J Med Spec 2020; 11: 132. Search in Google Scholar